Blood tests, breath studies and better CT scans could all help detect lung cancers earlier. We investigate the latest research that could inform lung screening.
Researchers are trying to diagnose lung cancer early through screening, and studying if the benefits of early detection outweigh the harms.
Cancer Research UK, the Francis Crick Institute and Bristol-Myers Squibb join forces to map out lung cancer immunology
This collaboration will help develop a ‘rule book’ to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments.
Scientists are turning to crime-mapping tech as a new way to look at cancer.
Some patients with lung cancer will be able to receive an immunotherapy drug with standard chemotherapy on the NHS in England.
Mirati Therapeutics, Inc. is the latest partner of Cancer Research UK’s Stratified Medicine Programme.
We don't always know why never-smokers develop lung cancer, but the data suggests that genetics play a role, as well as environmental or occupational exposures.
Scientists have identified a key molecular player in a subtype of lung cancer, which could lead to a new way to tackle the disease.
A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.